The prognostic value of different factors upon diagnosis of CML was analysed in 45
Philadelphia (Ph1)-positive patients. The median survival was 48 months. Univariate …

The prognostic value of different clinical and laboratory findings at diagnosis of chronic
myeloid leukemia (CML) was analyzed in a series of 121 cytogenetically studied patients …

The clinical course of 196 patients with chronic myelocytic leukemia (CML) was studied.
Prognostic factors were analyzed using a standard prognostic model. From a univariate …

CML is best regarded as a benign neoplasm, which regularly transforms into a rapidly fatal
malignant one. Survival is determined by the timing of disease transformation. The rate of …

PURPOSE Since interferon alfa (IFN-A) became an established treatment in chronic
myelogenous leukemia (CML), more patients are referred to tertiary centers in late chronic …

Determination of the characteristics of accelerated disease in chronic myelogenous
leukemia (CML) helps in individual prognostication, and in the introduction and analysis of …

The prognostic value of several clinical and hematologic features, recorded at diagnosis, in
chronic phase Ph1 positive chronic myelocytic leukemia (CML), was analyzed in 135 …

e18529 Background: Chronic myeloid leukaemia (CML) patients commonly complain of
abdominal swelling and pain. Presentations like hearing loss, visual impairment and …

Clinical and laboratory findings at the time of diagnosis were correlated with the survival of
242 patients with chronic myelocytic leukemia. Twelve patients with the blastic stage of the …

Chronic myelogenous leukemia (CML) is a chronic myeloproliferative disorder with an
initially chronic course lasting for 3–5 years. It eventually transforms into accelerated and …